Article

Vacation is prize

If you sell either or both of two brands of polarized lenses (Coppertone and SunRx, Vision-Ease Lens [VEL]), you can enter a drawing to win a grand prize vacation through a new ?Endless Summer? promotion.

Ramsey, MN-If you sell either or both of two brands of polarized lenses (Coppertone and SunRx, Vision-Ease Lens [VEL]), you can enter a drawing to win a grand prize vacation through a new “Endless Summer” promotion.

Retailers may earn three tickets for each pair of one of the brands (Coppertone) sold and one ticket for each pair of the other brand sold April 1 through July 31. At the end of the promotion, VEL will inform each registered retailer of the number of tickets for which they qualify. Retailers then will assign individual dispenser names to entries and return them to VEL. The grand prize, a vacation with a destination of the winner’s choosing, and hundreds of other prizes including backpacks, t-shirts, and more, will be drawn 3 to 5 weeks after the promotion ends.

Visit the section for professionals at www.vision-ease.com to access details and sign up for the promotion.

Launched in October 2007, one of the brands (Coppertone) has polarized lenses that block 100% of harmful ultraviolet (UV) A and UVB rays, according to the company. These lenses are designed to offer more protection from high-energy visible (HEV) light than ordinary lenses.

The lenses of the other brand (SunRx) eliminate 99% of reflected glare, are scratch-resistant, and are up to 10 times more impact-resistant than ordinary sun lenses, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.